Industry Research Reports

Home > Reports > Service & Software > Global Pharmaceutical CXO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Pharmaceutical CXO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 113 Pages

Report ld: 4024990

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Pharmaceutical CXO market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.

In the process of new drug development, through pharmaceutical contract outsourcing, pharmaceutical companies or biotechnology companies commission drug R&D and production companies to provide professional R&D services, including technical process development, API and CCMO production, formulation production, etc.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Pharmaceutical CXO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical CXO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

WuXi AppTec
Tigermed
Charles River Laboratories
Pharmaron Inc
Labcorp Drug Development
Boehringer Ingelheim
GenScript
MabPlex International
Shanghai ChemPartner
Wuxi Biologics
Pharmablock
Jiuzhou Pharma
Asym Chemical
IQVIA
Syneos Health
Parexel
AGC Biologics
FUJIFILM Diosynth Biotechnologies
Patheon
Catalent
Lonza Group AG
Avid Bioservices
AbbVie

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

CRO
CMO
CDMO

Segment by Application

Pharmaceutical Companies
Biotechnology Companies

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Pharmaceutical CXO in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Pharmaceutical CXO manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CXO revenue, gross margin, and recent development, etc.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 CRO

1.2.3 CMO

1.2.4 CDMO

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 Biotechnology Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical CXO Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Pharmaceutical CXO Revenue Market Share by Region (2020-2025)

2.4 Global Pharmaceutical CXO Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Pharmaceutical CXO Market Size and Prospective (2020-2031)

2.5.2 Europe Pharmaceutical CXO Market Size and Prospective (2020-2031)

2.5.3 Asia-Pacific Pharmaceutical CXO Market Size and Prospective (2020-2031)

2.5.4 Latin America Pharmaceutical CXO Market Size and Prospective (2020-2031)

2.5.5 Middle East & Africa Pharmaceutical CXO Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Pharmaceutical CXO Historic Market Size by Type (2020-2025)

3.2 Global Pharmaceutical CXO Forecasted Market Size by Type (2026-2031)

3.3 Different Types Pharmaceutical CXO Representative Players

4 Breakdown Data by Application

4.1 Global Pharmaceutical CXO Historic Market Size by Application (2020-2025)

4.2 Global Pharmaceutical CXO Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Pharmaceutical CXO Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Pharmaceutical CXO Players by Revenue (2020-2025)

5.1.2 Global Pharmaceutical CXO Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Pharmaceutical CXO Revenue

5.4 Global Pharmaceutical CXO Market Concentration Analysis

5.4.1 Global Pharmaceutical CXO Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CXO Revenue in 2024

5.5 Global Key Players of Pharmaceutical CXO Head office and Area Served

5.6 Global Key Players of Pharmaceutical CXO, Product and Application

5.7 Global Key Players of Pharmaceutical CXO, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Pharmaceutical CXO Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Pharmaceutical CXO Market Size by Type (2020-2025)

6.1.2.2 North America Pharmaceutical CXO Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Pharmaceutical CXO Market Size by Application (2020-2025)

6.1.3.2 North America Pharmaceutical CXO Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Pharmaceutical CXO Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Pharmaceutical CXO Market Size by Type (2020-2025)

6.2.2.2 Europe Pharmaceutical CXO Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Pharmaceutical CXO Market Size by Application (2020-2025)

6.2.3.2 Europe Pharmaceutical CXO Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 Asia-Pacific Market: Players, Segments and Downstream

6.3.1 Asia-Pacific Pharmaceutical CXO Revenue by Company (2020-2025)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Pharmaceutical CXO Market Size by Type (2020-2025)

6.3.2.2 Asia-Pacific Pharmaceutical CXO Market Share by Type (2020-2025)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Pharmaceutical CXO Market Size by Application (2020-2025)

6.3.3.2 Asia-Pacific Pharmaceutical CXO Market Share by Application (2020-2025)

6.3.4 Asia-Pacific Market Trend and Opportunities

6.4 Latin America Market: Players, Segments and Downstream

6.4.1 Latin America Pharmaceutical CXO Revenue by Company (2020-2025)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Pharmaceutical CXO Market Size by Type (2020-2025)

6.4.2.2 Latin America Pharmaceutical CXO Market Share by Type (2020-2025)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Pharmaceutical CXO Market Size by Application (2020-2025)

6.4.3.2 Latin America Pharmaceutical CXO Market Share by Application (2020-2025)

6.4.4 Latin America Market Trend and Opportunities

6.5 Middle East & Africa Market: Players, Segments and Downstream

6.5.1 Middle East & Africa Pharmaceutical CXO Revenue by Company (2020-2025)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Pharmaceutical CXO Market Size by Type (2020-2025)

6.5.2.2 Middle East & Africa Pharmaceutical CXO Market Share by Type (2020-2025)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Pharmaceutical CXO Market Size by Application (2020-2025)

6.5.3.2 Middle East & Africa Pharmaceutical CXO Market Share by Application (2020-2025)

6.5.4 Middle East & Africa Market Trend and Opportunities

7 Key Players Profiles

7.1 WuXi AppTec

7.1.1 WuXi AppTec Company Details

7.1.2 WuXi AppTec Business Overview

7.1.3 WuXi AppTec Pharmaceutical CXO Introduction

7.1.4 WuXi AppTec Revenue in Pharmaceutical CXO Business (2020-2025)

7.1.5 WuXi AppTec Recent Development

7.2 Tigermed

7.2.1 Tigermed Company Details

7.2.2 Tigermed Business Overview

7.2.3 Tigermed Pharmaceutical CXO Introduction

7.2.4 Tigermed Revenue in Pharmaceutical CXO Business (2020-2025)

7.2.5 Tigermed Recent Development

7.3 Charles River Laboratories

7.3.1 Charles River Laboratories Company Details

7.3.2 Charles River Laboratories Business Overview

7.3.3 Charles River Laboratories Pharmaceutical CXO Introduction

7.3.4 Charles River Laboratories Revenue in Pharmaceutical CXO Business (2020-2025)

7.3.5 Charles River Laboratories Recent Development

7.4 Pharmaron Inc

7.4.1 Pharmaron Inc Company Details

7.4.2 Pharmaron Inc Business Overview

7.4.3 Pharmaron Inc Pharmaceutical CXO Introduction

7.4.4 Pharmaron Inc Revenue in Pharmaceutical CXO Business (2020-2025)

7.4.5 Pharmaron Inc Recent Development

7.5 Labcorp Drug Development

7.5.1 Labcorp Drug Development Company Details

7.5.2 Labcorp Drug Development Business Overview

7.5.3 Labcorp Drug Development Pharmaceutical CXO Introduction

7.5.4 Labcorp Drug Development Revenue in Pharmaceutical CXO Business (2020-2025)

7.5.5 Labcorp Drug Development Recent Development

7.6 Boehringer Ingelheim

7.6.1 Boehringer Ingelheim Company Details

7.6.2 Boehringer Ingelheim Business Overview

7.6.3 Boehringer Ingelheim Pharmaceutical CXO Introduction

7.6.4 Boehringer Ingelheim Revenue in Pharmaceutical CXO Business (2020-2025)

7.6.5 Boehringer Ingelheim Recent Development

7.7 GenScript

7.7.1 GenScript Company Details

7.7.2 GenScript Business Overview

7.7.3 GenScript Pharmaceutical CXO Introduction

7.7.4 GenScript Revenue in Pharmaceutical CXO Business (2020-2025)

7.7.5 GenScript Recent Development

7.8 MabPlex International

7.8.1 MabPlex International Company Details

7.8.2 MabPlex International Business Overview

7.8.3 MabPlex International Pharmaceutical CXO Introduction

7.8.4 MabPlex International Revenue in Pharmaceutical CXO Business (2020-2025)

7.8.5 MabPlex International Recent Development

7.9 Shanghai ChemPartner

7.9.1 Shanghai ChemPartner Company Details

7.9.2 Shanghai ChemPartner Business Overview

7.9.3 Shanghai ChemPartner Pharmaceutical CXO Introduction

7.9.4 Shanghai ChemPartner Revenue in Pharmaceutical CXO Business (2020-2025)

7.9.5 Shanghai ChemPartner Recent Development

7.10 Wuxi Biologics

7.10.1 Wuxi Biologics Company Details

7.10.2 Wuxi Biologics Business Overview

7.10.3 Wuxi Biologics Pharmaceutical CXO Introduction

7.10.4 Wuxi Biologics Revenue in Pharmaceutical CXO Business (2020-2025)

7.10.5 Wuxi Biologics Recent Development

7.11 Pharmablock

7.11.1 Pharmablock Company Details

7.11.2 Pharmablock Business Overview

7.11.3 Pharmablock Pharmaceutical CXO Introduction

7.11.4 Pharmablock Revenue in Pharmaceutical CXO Business (2020-2025)

7.11.5 Pharmablock Recent Development

7.12 Jiuzhou Pharma

7.12.1 Jiuzhou Pharma Company Details

7.12.2 Jiuzhou Pharma Business Overview

7.12.3 Jiuzhou Pharma Pharmaceutical CXO Introduction

7.12.4 Jiuzhou Pharma Revenue in Pharmaceutical CXO Business (2020-2025)

7.12.5 Jiuzhou Pharma Recent Development

7.13 Asym Chemical

7.13.1 Asym Chemical Company Details

7.13.2 Asym Chemical Business Overview

7.13.3 Asym Chemical Pharmaceutical CXO Introduction

7.13.4 Asym Chemical Revenue in Pharmaceutical CXO Business (2020-2025)

7.13.5 Asym Chemical Recent Development

7.14 IQVIA

7.14.1 IQVIA Company Details

7.14.2 IQVIA Business Overview

7.14.3 IQVIA Pharmaceutical CXO Introduction

7.14.4 IQVIA Revenue in Pharmaceutical CXO Business (2020-2025)

7.14.5 IQVIA Recent Development

7.15 Syneos Health

7.15.1 Syneos Health Company Details

7.15.2 Syneos Health Business Overview

7.15.3 Syneos Health Pharmaceutical CXO Introduction

7.15.4 Syneos Health Revenue in Pharmaceutical CXO Business (2020-2025)

7.15.5 Syneos Health Recent Development

7.16 Parexel

7.16.1 Parexel Company Details

7.16.2 Parexel Business Overview

7.16.3 Parexel Pharmaceutical CXO Introduction

7.16.4 Parexel Revenue in Pharmaceutical CXO Business (2020-2025)

7.16.5 Parexel Recent Development

7.17 AGC Biologics

7.17.1 AGC Biologics Company Details

7.17.2 AGC Biologics Business Overview

7.17.3 AGC Biologics Pharmaceutical CXO Introduction

7.17.4 AGC Biologics Revenue in Pharmaceutical CXO Business (2020-2025)

7.17.5 AGC Biologics Recent Development

7.18 FUJIFILM Diosynth Biotechnologies

7.18.1 FUJIFILM Diosynth Biotechnologies Company Details

7.18.2 FUJIFILM Diosynth Biotechnologies Business Overview

7.18.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Introduction

7.18.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CXO Business (2020-2025)

7.18.5 FUJIFILM Diosynth Biotechnologies Recent Development

7.19 Patheon

7.19.1 Patheon Company Details

7.19.2 Patheon Business Overview

7.19.3 Patheon Pharmaceutical CXO Introduction

7.19.4 Patheon Revenue in Pharmaceutical CXO Business (2020-2025)

7.19.5 Patheon Recent Development

7.20 Catalent

7.20.1 Catalent Company Details

7.20.2 Catalent Business Overview

7.20.3 Catalent Pharmaceutical CXO Introduction

7.20.4 Catalent Revenue in Pharmaceutical CXO Business (2020-2025)

7.20.5 Catalent Recent Development

7.21 Lonza Group AG

7.21.1 Lonza Group AG Company Details

7.21.2 Lonza Group AG Business Overview

7.21.3 Lonza Group AG Pharmaceutical CXO Introduction

7.21.4 Lonza Group AG Revenue in Pharmaceutical CXO Business (2020-2025)

7.21.5 Lonza Group AG Recent Development

7.22 Avid Bioservices

7.22.1 Avid Bioservices Company Details

7.22.2 Avid Bioservices Business Overview

7.22.3 Avid Bioservices Pharmaceutical CXO Introduction

7.22.4 Avid Bioservices Revenue in Pharmaceutical CXO Business (2020-2025)

7.22.5 Avid Bioservices Recent Development

7.23 AbbVie

7.23.1 AbbVie Company Details

7.23.2 AbbVie Business Overview

7.23.3 AbbVie Pharmaceutical CXO Introduction

7.23.4 AbbVie Revenue in Pharmaceutical CXO Business (2020-2025)

7.23.5 AbbVie Recent Development

8 Pharmaceutical CXO Market Dynamics

8.1 Pharmaceutical CXO Industry Trends

8.2 Pharmaceutical CXO Market Drivers

8.3 Pharmaceutical CXO Market Challenges

8.4 Pharmaceutical CXO Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Pharmaceutical CXO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Pharmaceutical CXO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Pharmaceutical CXO Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Pharmaceutical CXO Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Pharmaceutical CXO Revenue Share by Region (2020-2025)

Table 6. Global Pharmaceutical CXO Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Pharmaceutical CXO Revenue Share Forecast by Region (2026-2031)

Table 8. Global Pharmaceutical CXO Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Pharmaceutical CXO Revenue Market Share by Type (2020-2025)

Table 10. Global Pharmaceutical CXO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Pharmaceutical CXO Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Pharmaceutical CXO Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Pharmaceutical CXO Revenue Market Share by Application (2020-2025)

Table 15. Global Pharmaceutical CXO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Pharmaceutical CXO Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Pharmaceutical CXO Application

Table 18. Global Pharmaceutical CXO Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Pharmaceutical CXO Market Share by Players (2020-2025)

Table 20. Global Top Pharmaceutical CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CXO as of 2024)

Table 21. Ranking of Global Top Pharmaceutical CXO Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Pharmaceutical CXO Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Pharmaceutical CXO, Headquarters and Area Served

Table 24. Global Key Players of Pharmaceutical CXO, Product and Application

Table 25. Global Key Players of Pharmaceutical CXO, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Pharmaceutical CXO Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Pharmaceutical CXO Revenue Market Share by Company (2020-2025)

Table 29. North America Pharmaceutical CXO Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Pharmaceutical CXO Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Pharmaceutical CXO Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Pharmaceutical CXO Revenue Market Share by Company (2020-2025)

Table 33. Europe Pharmaceutical CXO Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Pharmaceutical CXO Market Size by Application (2020-2025) & (US$ Million)

Table 35. Asia-Pacific Pharmaceutical CXO Revenue by Company (2020-2025) & (US$ Million)

Table 36. Asia-Pacific Pharmaceutical CXO Revenue Market Share by Company (2020-2025)

Table 37. Asia-Pacific Pharmaceutical CXO Market Size by Type (2020-2025) & (US$ Million)

Table 38. Asia-Pacific Pharmaceutical CXO Market Size by Application (2020-2025) & (US$ Million)

Table 39. Latin America Pharmaceutical CXO Revenue by Company (2020-2025) & (US$ Million)

Table 40. Latin America Pharmaceutical CXO Revenue Market Share by Company (2020-2025)

Table 41. Latin America Pharmaceutical CXO Market Size by Type (2020-2025) & (US$ Million)

Table 42. Latin America Pharmaceutical CXO Market Size by Application (2020-2025) & (US$ Million)

Table 43. Middle East & Africa Pharmaceutical CXO Revenue by Company (2020-2025) & (US$ Million)

Table 44. Middle East & Africa Pharmaceutical CXO Revenue Market Share by Company (2020-2025)

Table 45. Middle East & Africa Pharmaceutical CXO Market Size by Type (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Pharmaceutical CXO Market Size by Application (2020-2025) & (US$ Million)

Table 47. WuXi AppTec Company Details

Table 48. WuXi AppTec Business Overview

Table 49. WuXi AppTec Pharmaceutical CXO Product

Table 50. WuXi AppTec Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 51. WuXi AppTec Recent Development

Table 52. Tigermed Company Details

Table 53. Tigermed Business Overview

Table 54. Tigermed Pharmaceutical CXO Product

Table 55. Tigermed Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 56. Tigermed Recent Development

Table 57. Charles River Laboratories Company Details

Table 58. Charles River Laboratories Business Overview

Table 59. Charles River Laboratories Pharmaceutical CXO Product

Table 60. Charles River Laboratories Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 61. Charles River Laboratories Recent Development

Table 62. Pharmaron Inc Company Details

Table 63. Pharmaron Inc Business Overview

Table 64. Pharmaron Inc Pharmaceutical CXO Product

Table 65. Pharmaron Inc Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 66. Pharmaron Inc Recent Development

Table 67. Labcorp Drug Development Company Details

Table 68. Labcorp Drug Development Business Overview

Table 69. Labcorp Drug Development Pharmaceutical CXO Product

Table 70. Labcorp Drug Development Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 71. Labcorp Drug Development Recent Development

Table 72. Boehringer Ingelheim Company Details

Table 73. Boehringer Ingelheim Business Overview

Table 74. Boehringer Ingelheim Pharmaceutical CXO Product

Table 75. Boehringer Ingelheim Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 76. Boehringer Ingelheim Recent Development

Table 77. GenScript Company Details

Table 78. GenScript Business Overview

Table 79. GenScript Pharmaceutical CXO Product

Table 80. GenScript Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 81. GenScript Recent Development

Table 82. MabPlex International Company Details

Table 83. MabPlex International Business Overview

Table 84. MabPlex International Pharmaceutical CXO Product

Table 85. MabPlex International Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 86. MabPlex International Recent Development

Table 87. Shanghai ChemPartner Company Details

Table 88. Shanghai ChemPartner Business Overview

Table 89. Shanghai ChemPartner Pharmaceutical CXO Product

Table 90. Shanghai ChemPartner Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 91. Shanghai ChemPartner Recent Development

Table 92. Wuxi Biologics Company Details

Table 93. Wuxi Biologics Business Overview

Table 94. Wuxi Biologics Pharmaceutical CXO Product

Table 95. Wuxi Biologics Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 96. Wuxi Biologics Recent Development

Table 97. Pharmablock Company Details

Table 98. Pharmablock Business Overview

Table 99. Pharmablock Pharmaceutical CXO Product

Table 100. Pharmablock Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 101. Pharmablock Recent Development

Table 102. Jiuzhou Pharma Company Details

Table 103. Jiuzhou Pharma Business Overview

Table 104. Jiuzhou Pharma Pharmaceutical CXO Product

Table 105. Jiuzhou Pharma Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 106. Jiuzhou Pharma Recent Development

Table 107. Asym Chemical Company Details

Table 108. Asym Chemical Business Overview

Table 109. Asym Chemical Pharmaceutical CXO Product

Table 110. Asym Chemical Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 111. Asym Chemical Recent Development

Table 112. IQVIA Company Details

Table 113. IQVIA Business Overview

Table 114. IQVIA Pharmaceutical CXO Product

Table 115. IQVIA Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 116. IQVIA Recent Development

Table 117. Syneos Health Company Details

Table 118. Syneos Health Business Overview

Table 119. Syneos Health Pharmaceutical CXO Product

Table 120. Syneos Health Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 121. Syneos Health Recent Development

Table 122. Parexel Company Details

Table 123. Parexel Business Overview

Table 124. Parexel Pharmaceutical CXO Product

Table 125. Parexel Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 126. Parexel Recent Development

Table 127. AGC Biologics Company Details

Table 128. AGC Biologics Business Overview

Table 129. AGC Biologics Pharmaceutical CXO Product

Table 130. AGC Biologics Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 131. AGC Biologics Recent Development

Table 132. FUJIFILM Diosynth Biotechnologies Company Details

Table 133. FUJIFILM Diosynth Biotechnologies Business Overview

Table 134. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product

Table 135. FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 136. FUJIFILM Diosynth Biotechnologies Recent Development

Table 137. Patheon Company Details

Table 138. Patheon Business Overview

Table 139. Patheon Pharmaceutical CXO Product

Table 140. Patheon Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 141. Patheon Recent Development

Table 142. Catalent Company Details

Table 143. Catalent Business Overview

Table 144. Catalent Pharmaceutical CXO Product

Table 145. Catalent Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 146. Catalent Recent Development

Table 147. Lonza Group AG Company Details

Table 148. Lonza Group AG Business Overview

Table 149. Lonza Group AG Pharmaceutical CXO Product

Table 150. Lonza Group AG Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 151. Lonza Group AG Recent Development

Table 152. Avid Bioservices Company Details

Table 153. Avid Bioservices Business Overview

Table 154. Avid Bioservices Pharmaceutical CXO Product

Table 155. Avid Bioservices Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 156. Avid Bioservices Recent Development

Table 157. AbbVie Company Details

Table 158. AbbVie Business Overview

Table 159. AbbVie Pharmaceutical CXO Product

Table 160. AbbVie Revenue in Pharmaceutical CXO Business (2020-2025) & (US$ Million)

Table 161. AbbVie Recent Development

Table 162. Pharmaceutical CXO Market Trends

Table 163. Pharmaceutical CXO Market Drivers

Table 164. Pharmaceutical CXO Market Challenges

Table 165. Pharmaceutical CXO Market Restraints

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceutical CXO Product Picture

Figure 2. Global Pharmaceutical CXO Market Share by Type: 2024 VS 2031

Figure 3. CRO Features

Figure 4. CMO Features

Figure 5. CDMO Features

Figure 6. Global Pharmaceutical CXO Market Share by Application: 2024 VS 2031

Figure 7. Pharmaceutical Companies

Figure 8. Biotechnology Companies

Figure 9. Pharmaceutical CXO Report Years Considered

Figure 10. Global Pharmaceutical CXO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 11. Global Pharmaceutical CXO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Pharmaceutical CXO Revenue Market Share by Region: 2020 VS 2024

Figure 13. North America Pharmaceutical CXO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 14. Europe Pharmaceutical CXO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. Asia-Pacific Pharmaceutical CXO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Latin America Pharmaceutical CXO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Middle East & Africa Pharmaceutical CXO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Global Pharmaceutical CXO Market Share by Players in 2024

Figure 19. Global Top Pharmaceutical CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CXO as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Pharmaceutical CXO Revenue in 2024

Figure 21. North America Pharmaceutical CXO Market Share by Type (2020-2025)

Figure 22. North America Pharmaceutical CXO Market Share by Application (2020-2025)

Figure 23. Europe Pharmaceutical CXO Market Share by Type (2020-2025)

Figure 24. Europe Pharmaceutical CXO Market Share by Application (2020-2025)

Figure 25. Asia-Pacific Pharmaceutical CXO Market Share by Type (2020-2025)

Figure 26. Asia-Pacific Pharmaceutical CXO Market Share by Application (2020-2025)

Figure 27. Latin America Pharmaceutical CXO Market Share by Type (2020-2025)

Figure 28. Latin America Pharmaceutical CXO Market Share by Application (2020-2025)

Figure 29. Middle East & Africa Pharmaceutical CXO Market Share by Type (2020-2025)

Figure 30. Middle East & Africa Pharmaceutical CXO Market Share by Application (2020-2025)

Figure 31. WuXi AppTec Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 32. Tigermed Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 33. Charles River Laboratories Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 34. Pharmaron Inc Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 35. Labcorp Drug Development Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 36. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 37. GenScript Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 38. MabPlex International Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 39. Shanghai ChemPartner Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 40. Wuxi Biologics Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 41. Pharmablock Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 42. Jiuzhou Pharma Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 43. Asym Chemical Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 44. IQVIA Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 45. Syneos Health Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 46. Parexel Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 47. AGC Biologics Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 48. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 49. Patheon Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 50. Catalent Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 51. Lonza Group AG Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 52. Avid Bioservices Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 53. AbbVie Revenue Growth Rate in Pharmaceutical CXO Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmaceutical CXO market? zhanKai

The top companies in the global Pharmaceutical CXO market are WuXi AppTec、Tigermed、Charles River Laboratories.

Related Reports

Pharmaceutical CXO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical CXO was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 142
USD 3950.00
(Single User License)
Global Pharmaceutical CXO Market Research Report 2026
The global Pharmaceutical CXO market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 153
USD 2900.00
(Single User License)
Global Pharmaceutical CXO Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical CXO market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 174
USD 4900.00
(Single User License)
Pharmaceutical CXO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical CXO was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 147
USD 3950.00
(Single User License)
Global Pharmaceutical CXO Market Research Report 2025
The global market for Pharmaceutical CXO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 107
USD 2900.00
(Single User License)
Global Pharmaceutical CXO Market Insights, Forecast to 2030
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.
Published Date: 2024-04-12
Pages: 125
USD 4900.00
(Single User License)
Global Pharmaceutical CXO Market Research Report 2024
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.
Published Date: 2024-02-06
Pages: 109
USD 2900.00
(Single User License)
Pharmaceutical CXO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.
Published Date: 2024-01-09
Pages: 141
USD 3950.00
(Single User License)

Pharmaceutical CXO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical CXO was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 142
USD 3950.00 (Single User License)
Global Pharmaceutical CXO Market Research Report 2026
The global Pharmaceutical CXO market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 153
USD 2900.00 (Single User License)
Global Pharmaceutical CXO Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical CXO market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 174
USD 4900.00 (Single User License)
Pharmaceutical CXO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical CXO was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 147
USD 3950.00 (Single User License)
Global Pharmaceutical CXO Market Research Report 2025
The global market for Pharmaceutical CXO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 107
USD 2900.00 (Single User License)
Global Pharmaceutical CXO Market Insights, Forecast to 2030
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.
Published: 2024-04-12
Pages: 125
USD 4900.00 (Single User License)
Global Pharmaceutical CXO Market Research Report 2024
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.
Published: 2024-02-06
Pages: 109
USD 2900.00 (Single User License)
Pharmaceutical CXO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.
Published: 2024-01-09
Pages: 141
USD 3950.00 (Single User License)